Cholinergic Pharmacology

Correct Answer

B — Irreversible acetylcholinesterase inhibitor

Rationale

Sarin is an organophosphate nerve agent classified as an irreversible acetylcholinesterase inhibitor. It forms a covalent bond with the serine residue at the active site of acetylcholinesterase, permanently inactivating the enzyme and causing acetylcholine to accumulate at all cholinergic synapses.

Correct Answer

D — Acetylcholinesterase reactivator

Rationale

Pralidoxime is classified as an acetylcholinesterase reactivator. It works by displacing the organophosphate group from the phosphorylated serine at the enzyme active site, restoring acetylcholinesterase activity. It is not an enzyme inhibitor, a receptor antagonist, or a direct-acting agent on gamma-aminobutyric acid receptors.

Correct Answer

A — Muscarinic receptor antagonist

Rationale

Atropine is a muscarinic receptor antagonist. It competitively blocks acetylcholine at muscarinic receptors, reversing the secretory, bronchospastic, and cardiovascular muscarinic effects produced by organophosphate poisoning. Atropine has no effect at nicotinic receptors and does not reactivate acetylcholinesterase.

Correct Answer

C — Organophosphate insecticide and irreversible acetylcholinesterase inhibitor

Rationale

Parathion is an organophosphate insecticide that acts as an irreversible acetylcholinesterase inhibitor. Unlike organophosphate nerve agents such as sarin, parathion was developed for agricultural use. It shares the same mechanism of irreversible enzyme inhibition but is classified as a pesticide rather than a chemical warfare agent. Carbamates also inhibit acetylcholinesterase but are a distinct chemical class and cause reversible inhibition.

Correct Answer

B — Gamma-aminobutyric acid-A receptor positive allosteric modulator

Rationale

Benzodiazepines are classified as gamma-aminobutyric acid-A receptor positive allosteric modulators. They bind to a site on the gamma-aminobutyric acid-A receptor distinct from the gamma-aminobutyric acid binding site and enhance the frequency of chloride channel opening in response to gamma-aminobutyric acid. This class designation distinguishes them from muscarinic antagonists, enzyme reactivators, and sodium channel blockers, all of which act through entirely different mechanisms.

Correct Answer

A — Organophosphate nerve agent

Rationale

VX is an organophosphate nerve agent, sharing its core mechanism with sarin and other nerve agents — irreversible inhibition of acetylcholinesterase through covalent phosphorylation of the active site serine. Vesicants such as mustard gas damage tissue through alkylation rather than cholinergic toxicity. Carbamates and cyanide compounds act through distinct mechanisms and are separate chemical classes.

Correct Answer

C — Covalent phosphorylation of the serine residue at the enzyme active site

Rationale

Organophosphates inhibit acetylcholinesterase by forming a stable covalent bond with the serine hydroxyl group at the enzyme active site. This phosphorylation permanently inactivates the enzyme, preventing it from hydrolyzing acetylcholine. The result is acetylcholine accumulation at all cholinergic synapses — muscarinic, nicotinic, and central. The inhibition is irreversible under physiological conditions unless an oxime reactivator is administered before aging occurs.

Correct Answer

D — The organophosphate-enzyme bond undergoes a secondary reaction that makes it resistant to nucleophilic attack

Rationale

After organophosphate compounds phosphorylate the acetylcholinesterase active site serine, the phosphorylated enzyme undergoes a time-dependent process called aging. Aging involves loss of an alkyl group from the phosphate moiety, creating a negatively charged complex that is highly stable and resistant to nucleophilic displacement by pralidoxime. Once aging is complete, pralidoxime cannot break the bond and the enzyme inhibition is permanent. The window for pralidoxime effectiveness varies by agent but is typically hours.

Correct Answer

A — It attacks the phosphorylated serine and displaces the organophosphate group, freeing the active site

Rationale

Pralidoxime acts as a nucleophile that attacks the phosphorus atom of the organophosphate-serine complex. This nucleophilic substitution reaction displaces the organophosphate group from the serine residue, regenerating the free hydroxyl group at the active site and restoring enzyme activity. Pralidoxime does not stimulate enzyme synthesis, does not act before phosphorylation occurs, and does not chelate organophosphates in the blood. It must be given before aging renders the bond resistant to this reaction.

Correct Answer

B — Muscarinic receptors at glands and smooth muscle

Rationale

Salivation, lacrimation, urination, defecation, gastrointestinal distress, and emesis — collectively abbreviated as the SLUDGE toxidrome — represent the secretory and smooth muscle effects of acetylcholine excess at muscarinic receptors. Exocrine glands and smooth muscle are innervated by postganglionic parasympathetic fibers that release acetylcholine onto muscarinic receptors. Nicotinic receptor overstimulation produces a separate set of findings including muscle fasciculations, weakness, and autonomic ganglionic effects.

Correct Answer

D — Atropine has no activity at nicotinic receptors, leaving neuromuscular junction dysfunction unaddressed

Rationale

Atropine is selective for muscarinic receptors and has no clinically meaningful activity at nicotinic receptors. In organophosphate poisoning, acetylcholine accumulation at the neuromuscular junction produces continuous depolarization, causing initial fasciculations followed by flaccid paralysis of skeletal muscle including the diaphragm and intercostal muscles. Atropine reverses the secretory and bronchospastic muscarinic effects but cannot restore normal neuromuscular junction function. Pralidoxime, by reactivating acetylcholinesterase, addresses both muscarinic and nicotinic components of the toxidrome.

Correct Answer

C — Bronchospasm and hypersecretion from muscarinic overstimulation combine with neuromuscular paralysis from nicotinic overstimulation and central respiratory depression

Rationale

Respiratory failure in organophosphate poisoning arises from three converging mechanisms. Muscarinic overstimulation produces bronchospasm and profuse airway secretions, obstructing airflow. Nicotinic overstimulation at the neuromuscular junction causes progressive flaccid paralysis of the diaphragm and intercostal muscles, eliminating the mechanical drive for breathing. Central nervous system accumulation of acetylcholine depresses brainstem respiratory centers. These three mechanisms act simultaneously, making respiratory failure difficult to reverse and requiring both pharmacological treatment and mechanical ventilatory support.

Correct Answer

A — Hepatic oxidation converts parathion to paraoxon, the active acetylcholinesterase inhibitor

Rationale

Parathion belongs to the thiono-organophosphate subclass, characterized by a sulfur atom double-bonded to phosphorus in place of oxygen. This thiono group confers low intrinsic acetylcholinesterase inhibitory activity. In the liver, cytochrome P450 enzymes oxidize the thiono sulfur to oxygen, converting parathion to paraoxon — the active oxon form that potently inhibits acetylcholinesterase. This hepatic bioactivation step explains why thiono-organophosphates have a delayed onset of toxicity compared to direct-acting nerve agents, and why liver function affects the degree of poisoning.

Correct Answer

B — Drying of secretions and clearing of bronchospasm

Rationale

The goal of atropine therapy in organophosphate poisoning is to reverse the life-threatening muscarinic effects on the airways and secretory glands. The correct clinical endpoint is drying of bronchial and oral secretions and resolution of bronchospasm, which together address the primary respiratory threat. Heart rate is not a reliable titration endpoint because tachycardia from organophosphate-induced nicotinic stimulation at autonomic ganglia can make the baseline rate unreliable, and pupil size is too variable and non-specific. Fasciculations and muscle weakness are nicotinic effects that atropine cannot address regardless of dose.

Correct Answer

D — Competitive blockade of acetylcholine at muscarinic receptors on glands and smooth muscle

Rationale

This patient has organophosphate poisoning from pesticide exposure, presenting with the muscarinic toxidrome of hypersalivation, miosis, and bronchospasm with secretions. Atropine, a muscarinic receptor antagonist, directly addresses these airway and secretory findings by competitively blocking the excess acetylcholine at muscarinic receptors on exocrine glands and bronchial smooth muscle. This mechanism dries secretions and relieves bronchospasm. Pralidoxime acts by displacing organophosphate from acetylcholinesterase, addressing the underlying enzyme inhibition but not acting directly on muscarinic receptors.

Correct Answer

A — Nucleophilic displacement of the organophosphate group from the acetylcholinesterase active site, restoring enzyme activity

Rationale

The persistent skeletal muscle weakness reflects nicotinic receptor overstimulation at the neuromuscular junction, which atropine cannot address. Pralidoxime is the appropriate addition. It acts as a nucleophile that attacks the phosphorylated serine at the acetylcholinesterase active site, displacing the organophosphate and restoring the enzyme's ability to hydrolyze acetylcholine. By reducing acetylcholine accumulation at the neuromuscular junction, pralidoxime allows normal neuromuscular transmission to resume and reverses the paralysis, provided the drug is given before aging of the phosphorylated enzyme occurs.

Correct Answer

C — Positive allosteric modulation of gamma-aminobutyric acid-A receptors, increasing chloride influx and reducing neuronal excitability

Rationale

Organophosphate-induced seizures arise from acetylcholine accumulation in the central nervous system, which produces excessive excitatory drive through muscarinic and nicotinic mechanisms in the brain. Benzodiazepines are the first-line anticonvulsants in this setting. They act as positive allosteric modulators at gamma-aminobutyric acid-A receptors, enhancing the inhibitory effect of gamma-aminobutyric acid by increasing the frequency of chloride channel opening. This increased chloride influx hyperpolarizes neurons and raises the seizure threshold. Benzodiazepines are preferred over sodium channel blockers in organophosphate poisoning because the mechanism is well matched to the underlying neurochemical disturbance.

Correct Answer

B — The soman-acetylcholinesterase complex underwent aging, creating a stable bond that pralidoxime cannot displace

Rationale

Soman is notable for having one of the shortest aging times among organophosphate nerve agents — aging can occur within minutes to hours after exposure. Aging refers to the loss of an alkyl group from the phosphorylated serine complex, which converts the bond to a highly stable, negatively charged form that is resistant to nucleophilic attack by pralidoxime. By 18 hours after soman exposure, aging is complete and pralidoxime cannot restore enzyme activity regardless of the dose administered. This pharmacological characteristic of soman makes rapid administration of pralidoxime especially time-sensitive and illustrates why aging time is a clinically relevant property of different organophosphate agents.